Company / Tangible Book Value per Share
Acadia Pharmaceuticals Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.36
FY2025
5-year range
$2.49 / $7.36
FY2021-FY2025
Trend
+65.4%
vs FY2024
Sector context
#70 of 209
Health Care
What the data says
At $7.36, Acadia Pharmaceuticals's tangible book value per share ranks #70 of 209 in the Health Care sector. Tangible Book Value per Share has increased for 3 consecutive years, from $2.49 in FY2022 to $7.36 in FY2025.
Based on SEC 10-K filings.
7.36 in FY2025 with a 5-year CAGR of +12.8%.
Improved from $2.66 to $7.36 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +43.6%
- 5-Year CAGR
- +12.8%
- 10-Year CAGR
- -
Sector benchmark
#70 of 209 in Health CareTop 33% of 209This company $7.36 Sector average $119.74
▼
-93.9% below sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's tangible book value per share has grown for 3 consecutive years.
- In FY2025, tangible book value per share increased 65.4% year-over-year.
- Ranks #70 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.36 | +65.4% |
| FY2024 | $4.45 | +67.1% |
| FY2023 | $2.66 | +7.1% |
| FY2022 | $2.49 | -26.6% |
| FY2021 | $3.39 | -16.1% |
| FY2020 | $4.04 | -16.9% |
| FY2019 | $4.86 | +26.2% |
| FY2018 | $3.85 | +39.4% |
| FY2017 | $2.76 | -45.7% |
| FY2016 | $5.09 | +154.7% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026